These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16395417)

  • 1. Effect of paroxetine on marble-burying behavior in mice.
    Shinomiya K; Fujii Y; Sugimoto Y; Azuma N; Tokunaga S; Kitazumi K; Kamei C
    Methods Find Exp Clin Pharmacol; 2005 Dec; 27(10):685-7. PubMed ID: 16395417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine.
    Egashira N; Harada S; Okuno R; Matsushita M; Nishimura R; Mishima K; Iwasaki K; Orito K; Fujiwara M
    Eur J Pharmacol; 2007 Jun; 563(1-3):149-54. PubMed ID: 17349995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran on marble burying behavior in mice.
    Sugimoto Y; Tagawa N; Kobayashi Y; Hotta Y; Yamada J
    Biol Pharm Bull; 2007 Dec; 30(12):2399-401. PubMed ID: 18057733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine.
    Fujishiro J; Imanishi T; Onozawa K; Tsushima M
    Eur J Pharmacol; 2002 Nov; 454(2-3):183-8. PubMed ID: 12421645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of 5-hydroxytryptamine2C receptors in marble-burying behavior in mice.
    Egashira N; Okuno R; Shirakawa A; Nagao M; Mishima K; Iwasaki K; Oishi R; Fujiwara M
    Biol Pharm Bull; 2012; 35(3):376-9. PubMed ID: 22382324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
    Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice.
    Ichimaru Y; Egawa T; Sawa A
    Jpn J Pharmacol; 1995 May; 68(1):65-70. PubMed ID: 7494384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antipsychotic trifluoperazine reduces marble-burying behavior in mice via D
    Egashira N; Kubota N; Goto Y; Watanabe T; Kubota K; Katsurabayashi S; Iwasaki K
    Pharmacol Biochem Behav; 2018 Feb; 165():9-13. PubMed ID: 29273456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nitric oxide in obsessive-compulsive behavior and its involvement in the anti-compulsive effect of paroxetine in mice.
    Umathe SN; Bhutada PS; Jain NS; Mundhada YR; Borkar SS; Dhumal B
    Nitric Oxide; 2009 Sep; 21(2):140-7. PubMed ID: 19584001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreases in nestlet shredding of mice by serotonin uptake inhibitors: comparison with marble burying.
    Li X; Morrow D; Witkin JM
    Life Sci; 2006 Mar; 78(17):1933-9. PubMed ID: 16182315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetyl-L-cysteine inhibits marble-burying behavior in mice.
    Egashira N; Shirakawa A; Abe M; Niki T; Mishima K; Iwasaki K; Oishi R; Fujiwara M
    J Pharmacol Sci; 2012; 119(1):97-101. PubMed ID: 22510519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT 2A receptor antagonistic activity, on a marble-burying behavior test as an obsessive-compulsive disorder model.
    Takeuchi H; Yatsugi S; Yamaguchi T
    Jpn J Pharmacol; 2002 Oct; 90(2):197-200. PubMed ID: 12419892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perospirone, a novel antipsychotic drug, inhibits marble-burying behavior via 5-HT1A receptor in mice: implications for obsessive-compulsive disorder.
    Matsushita M; Egashira N; Harada S; Okuno R; Mishima K; Iwasaki K; Nishimura R; Fujiwara M
    J Pharmacol Sci; 2005 Oct; 99(2):154-9. PubMed ID: 16210777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide is involved in the regulation of marble-burying behavior.
    Krass M; Rünkorg K; Wegener G; Volke V
    Neurosci Lett; 2010 Aug; 480(1):55-8. PubMed ID: 20553994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors.
    Casarotto PC; Gomes FV; Resstel LB; Guimarães FS
    Behav Pharmacol; 2010 Jul; 21(4):353-8. PubMed ID: 20695034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Psilocybe argentipes on marble-burying behavior in mice.
    Matsushima Y; Shirota O; Kikura-Hanajiri R; Goda Y; Eguchi F
    Biosci Biotechnol Biochem; 2009 Aug; 73(8):1866-8. PubMed ID: 19661714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.
    Egashira N; Okuno R; Matsushita M; Abe M; Mishima K; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
    Eur J Pharmacol; 2008 Sep; 592(1-3):103-8. PubMed ID: 18644366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of serotonin type 1A receptors in fluvoxamine-induced inhibition of marble-burying behavior in mice.
    Harasawa T; Ago Y; Itoh S; Baba A; Matsuda T
    Behav Pharmacol; 2006 Nov; 17(7):637-40. PubMed ID: 17021397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereospecific blockade of marble-burying behaviour in mice by selective, non-peptidergic neurokinin1 (NK1) receptor antagonists.
    Millan MJ; Girardon S; Mullot J; Brocco M; Dekeyne A
    Neuropharmacology; 2002 Apr; 42(5):677-84. PubMed ID: 11985826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mood stabilizers on marble-burying behavior in mice: involvement of GABAergic system.
    Egashira N; Abe M; Shirakawa A; Niki T; Mishima K; Iwasaki K; Oishi R; Fujiwara M
    Psychopharmacology (Berl); 2013 Mar; 226(2):295-305. PubMed ID: 23086022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.